MarketBeat.com | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Recro Pharma Company Profile (NASDAQ:REPH)

Consensus Ratings for Recro Pharma (NASDAQ:REPH) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $28.67 (248.11% upside)

Analysts' Ratings History for Recro Pharma (NASDAQ:REPH)
Show:
DateFirmActionRatingPrice TargetActions
4/14/2015Brean CapitalSet Price TargetBuy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2015MLV & Co.Boost Price TargetBuy$12.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2015Brean CapitalReiterated RatingBuy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014AegisDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/5/2014AegisLower Price Target$40.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/12/2014AegisInitiated CoverageBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2014Brean CapitalInitiated CoverageBuy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/1/2013 forward)